Ticker Report Metagenomi (NASDAQ:MGX - Get Free Report) and Agenus (NASDAQ:AGEN - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based...\n more…
PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...\n more…
Ticker Report Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) CFO Pamela Wapnick sold 6,265 shares of Metagenomi stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of...\n more…
Ticker Report Metagenomi (NASDAQ:MGX - Get Free Report)s stock had its "buy" rating reiterated by Chardan Capital in a research report issued to clients and investors on Thursday, Benzinga reports. They...\n more…
Benzinga 6 analysts have shared their evaluations of Metagenomi MGX during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.\n more…